New Istanbul office for World Courier
World Courier has strengthened its presence in the Turkish market by opening an office in Istanbul.
Read MorePosted by Ian Taylor | Jan 11, 2011 | News |
World Courier has strengthened its presence in the Turkish market by opening an office in Istanbul.
Read MorePosted by Ian Taylor | Aug 10, 2010 | News |
World Courier breaks ground on new 135,000 square foot state-of-the-art facility in Singapore.
Read MoreIn response to increasing demand from global pharmaceutical companies that conduct clinical trials in India, World Courier will almost triple the capacity of its ISO-certified, GMP-compliant investigational storage facility in Bangalore during 2008. The expansion will be undertaken in two phases, with the first phase being completed by the end of January and the second phase set to get under way in April. The facility will remain open for business throughout the construction period.
The delivery of this expanded state-of-the-art temperature-controlled structure to the international research community follows ground-breaking 2004 patent legislation governing the molecular composition of new and existing drugs. Since then, the progressive legislation – combined with the country’s widely varied and densely populated demographics – has attracted growing numbers of the pharmaceutical community to a local clinical trial market that is expected to exceed USD 1.5 billion (U.S.) in investment by 2010.
World Courier currently maintains a network of seven investigational drug storage facilities worldwide, with installations in Buenos Aires (Argentina), Sao Paulo (Brazil), Santiago (Chile), Mexico City (Mexico), Lima (Peru), Moscow (Russia) and Bangalore (India). Five new global locations are planned to come online in strategic and developing markets during 2008, increasing World Courier’s network of temperature-controlled biopharm facilities to 12 worldwide.
Read MoreWorld Courier World Courier, the US-based international courier network, is targeting the booming Chinese pharmaceutical sector by extending its cold chain network to 36 major cities in the country, including provincial capitals.
“China is poised to become the fourth largest pharmaceutical market by 2012,” said Henning Voss, director for World Courier North Asia. But he noted: “China presents many infrastructure challenges for temperature-controlled and clinical trial shipments. Domestic transport companies do not yet fully understand the many international standards at play in handling these types of shipments. As such, the real concerns and requirements of major pharmaceutical clients in China have not been adequately addressed until now.”
With its new operational network, World Courier could help pharmaceutical companies, central labs and clinical research organizations improve their supply chain efficiencies, Voss said. All temperature-sensitive pharmaceutical and clinical trial shipments are handled by trained personnel according to established operating practices and IATA transportation standards. Only validated packaging complete with industry-accepted cold-pack mediums and temperature recording devices are used.
Read MoreDetails and services of In-Night Logistic Service providers
Read More
Post & Parcel Magazine is our print publication, released 3 times a year. Packed with original content and thought-provoking features, Post & Parcel Magazine is a must-read for those who want the inside track on the industry.